Scholar Rock Holding (FRA:2QK) Growth Rank: 0 (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2QK Scholar Rock Holding Corp FRA:2QK
48 GF Score
Price €41.36
GF Value €25.26
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Scholar Rock Holding Growth Rank?

Scholar Rock Holding has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Scholar Rock Holding Growth Rank Related Terms

FRA:2QK
48GF Score
Scholar Rock Holding Corp FRA:2QK
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Scholar Rock Holding (FRA:2QK) Overvalued in 2026?

Based on GuruFocus' analysis, Scholar Rock Holding stock appears to be overvalued. The current stock price of €41.36 is trading 63.7% above its estimated GF Value™ of €25.26. GuruFocus considers Scholar Rock Holding to be Significantly Overvalued.

Key valuation signals for FRA:2QK:

  • Growth Rank: 0
  • GF Value™: €25.26 vs. price of €41.36 (63.7% above fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the FRA:2QK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scholar Rock Holding Business Description

Other Exchanges SRRK:USA2QK:Germany
Address 301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
48GF Score

Get the complete analysis for FRA:2QK

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.36
Price
€25.26
GF Value